- Title
-
Assessing developmental toxicity and non-CYP mediated biotransformation of two anti-epileptics and their human metabolites in zebrafish embryos and larvae
- Authors
- Hoyberghs, J., Coppens, A., Bars, C., Van Ginneken, C., Foubert, K., Van Cruchten, S.
- Source
- Full text @ Curr Res Toxicol
Proposed pathway of carbamazepine in humans by myeloperoxidases in activated leukocytes |
Proposed pathway of carbamazepine in humans. Metabolism in the liver is indicated with broken arrows. Metabolism in the peripheral blood is indicated with continuous arrows |
Larvae exposed to CBZ or AI at 120 hpf. A) Control larva (1 % DMSO) showing no signs of abnormalities. B) Larva treated with 250 µM CBZ. C) Larva treated with 500 µM CBZ. D) Larva treated with 30 µM AI. The larvae depicted in B, C and D show several malformations. Abbreviations: acridine (AI), carbamazepine (CBZ), edema eyes (EE), edema head (EH), edema pericard (EP), increased pigmentation (IP), malformation yolk (MY), no hatching (NH). |
Larvae exposed to AO or 9ACA at 120 hpf. A) Control larva (1 % DMSO) showing no signs of abnormalities. B) Larva treated with 30 µM AO. C) Larva treated with 60 µM AO. D) Larva treated with 30 µM 9ACA. E) Larva treated with 60 µM 9ACA. The larvae depicted in B, C, D and E show several malformations. Abbreviations: 9-acridine carboxaldehyde (9ACA), acridone (AO), curved tail (CT), deviation eyes (shape) (DES), edema eyes (EE), edema head (EH), edema pericard (EP), increased pigmentation (IP), malformation yolk (bigger) (MYB), no hatching (NH). |